Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth

We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin (recombinant growth hormone; GH; 10 mg/48 hours injected)...

Full description

Bibliographic Details
Main Authors: Brown, D.M., Williams, H., Ryan, K.J.P., Wilson, T.L., Daniel, Zoe, Mareko, M.H.D., Emes, Richard D., Harris, D.W., Jones, Sarah, Wattis, Jonathan A.D., Dryden, Ian L., Hodgman, Charlie, Brameld, John M., Parr, Tim
Format: Article
Published: Nature Publishing Group 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/34595/
_version_ 1848794890070130688
author Brown, D.M.
Williams, H.
Ryan, K.J.P.
Wilson, T.L.
Daniel, Zoe
Mareko, M.H.D.
Emes, Richard D.
Harris, D.W.
Jones, Sarah
Wattis, Jonathan A.D.
Dryden, Ian L.
Hodgman, Charlie
Brameld, John M.
Parr, Tim
author_facet Brown, D.M.
Williams, H.
Ryan, K.J.P.
Wilson, T.L.
Daniel, Zoe
Mareko, M.H.D.
Emes, Richard D.
Harris, D.W.
Jones, Sarah
Wattis, Jonathan A.D.
Dryden, Ian L.
Hodgman, Charlie
Brameld, John M.
Parr, Tim
author_sort Brown, D.M.
building Nottingham Research Data Repository
collection Online Access
description We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin (recombinant growth hormone; GH; 10 mg/48 hours injected) and compared to a control cohort (feed only; no injections) over a 27-day time course (1, 3, 7, 13 or 27-days). Longissimus Dorsi muscle gene expression was analyzed using Agilent porcine transcriptome microarrays and clusters of genes displaying similar expression profiles were identified using a modified maSigPro clustering algorithm. Anabolic agents increased carcass (p = 0.002) and muscle weights (Vastus Lateralis: p < 0.001; Semitendinosus: p = 0.075). Skeletal muscle mRNA expression of serine/one-carbon/glycine biosynthesis pathway genes (Phgdh, Psat1 and Psph) and the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), increased during treatment with BA, and to a lesser extent GH (p < 0.001, treatment x time interaction). Treatment with BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expression at days 3 (p < 0.05) and 7 (p < 0.01), and a 2-fold increase in PEPCK-M protein expression at day 7 (p < 0.01). BA treated pigs exhibit a profound increase in expression of PHGDH and PEPCK-M in skeletal muscle, implicating a role for biosynthetic metabolic pathways in muscle growth.
first_indexed 2025-11-14T19:23:22Z
format Article
id nottingham-34595
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:23:22Z
publishDate 2016
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-345952020-05-04T17:54:51Z https://eprints.nottingham.ac.uk/34595/ Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth Brown, D.M. Williams, H. Ryan, K.J.P. Wilson, T.L. Daniel, Zoe Mareko, M.H.D. Emes, Richard D. Harris, D.W. Jones, Sarah Wattis, Jonathan A.D. Dryden, Ian L. Hodgman, Charlie Brameld, John M. Parr, Tim We aimed to identify novel molecular mechanisms for muscle growth during administration of anabolic agents. Growing pigs (Duroc/(Landrace/Large-White)) were administered Ractopamine (a beta-adrenergic agonist; BA; 20 ppm in feed) or Reporcin (recombinant growth hormone; GH; 10 mg/48 hours injected) and compared to a control cohort (feed only; no injections) over a 27-day time course (1, 3, 7, 13 or 27-days). Longissimus Dorsi muscle gene expression was analyzed using Agilent porcine transcriptome microarrays and clusters of genes displaying similar expression profiles were identified using a modified maSigPro clustering algorithm. Anabolic agents increased carcass (p = 0.002) and muscle weights (Vastus Lateralis: p < 0.001; Semitendinosus: p = 0.075). Skeletal muscle mRNA expression of serine/one-carbon/glycine biosynthesis pathway genes (Phgdh, Psat1 and Psph) and the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), increased during treatment with BA, and to a lesser extent GH (p < 0.001, treatment x time interaction). Treatment with BA, but not GH, caused a 2-fold increase in phosphoglycerate dehydrogenase (PHGDH) protein expression at days 3 (p < 0.05) and 7 (p < 0.01), and a 2-fold increase in PEPCK-M protein expression at day 7 (p < 0.01). BA treated pigs exhibit a profound increase in expression of PHGDH and PEPCK-M in skeletal muscle, implicating a role for biosynthetic metabolic pathways in muscle growth. Nature Publishing Group 2016-06-28 Article PeerReviewed Brown, D.M., Williams, H., Ryan, K.J.P., Wilson, T.L., Daniel, Zoe, Mareko, M.H.D., Emes, Richard D., Harris, D.W., Jones, Sarah, Wattis, Jonathan A.D., Dryden, Ian L., Hodgman, Charlie, Brameld, John M. and Parr, Tim (2016) Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth. Scientific Reports, 6 . p. 28693. ISSN 2045-2322 Ractopamine Reporcin Anabolic Pigs Metabolism Muscle http://www.nature.com/articles/srep28693 doi:10.1038/srep28693 doi:10.1038/srep28693
spellingShingle Ractopamine
Reporcin
Anabolic
Pigs
Metabolism
Muscle
Brown, D.M.
Williams, H.
Ryan, K.J.P.
Wilson, T.L.
Daniel, Zoe
Mareko, M.H.D.
Emes, Richard D.
Harris, D.W.
Jones, Sarah
Wattis, Jonathan A.D.
Dryden, Ian L.
Hodgman, Charlie
Brameld, John M.
Parr, Tim
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title_full Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title_fullStr Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title_full_unstemmed Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title_short Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
title_sort mitochondrial phosphoenolpyruvate carboxykinase (pepck-m) and serine biosynthetic pathway genes are co-ordinately increased during anabolic agent-induced skeletal muscle growth
topic Ractopamine
Reporcin
Anabolic
Pigs
Metabolism
Muscle
url https://eprints.nottingham.ac.uk/34595/
https://eprints.nottingham.ac.uk/34595/
https://eprints.nottingham.ac.uk/34595/